Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 3 | 0 | 0 | 3 |
GLS protein | 2 | 0 | 0 | 2 |
GLI family zinc finger 3 | 4 | 0 | 0 | 4 |
estrogen receptor 2 (ER beta) | 4 | 0 | 0 | 4 |
progesterone receptor | 5 | 0 | 0 | 5 |
retinoid X nuclear receptor alpha | 4 | 0 | 0 | 4 |
G | 3 | 0 | 0 | 3 |
peroxisome proliferator activated receptor gamma | 3 | 0 | 0 | 3 |
cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
chromobox protein homolog 1 | 2 | 0 | 0 | 2 |
potassium voltage-gated channel subfamily H member 2 isoform d | 2 | 0 | 0 | 2 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 2 | 0 | 0 | 2 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
geminin | 3 | 0 | 0 | 3 |
lamin isoform A-delta10 | 2 | 0 | 0 | 2 |
ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 4 | 0 | 1 | 0 | 1 |
Bile salt export pump | 0 | 2 | 0 | 2 |
Interferon beta | 3 | 0 | 0 | 3 |
HLA class I histocompatibility antigen, B alpha chain | 3 | 0 | 0 | 3 |
Transthyretin | 0 | 0 | 3 | 5 |
Mitogen-activated protein kinase 1 | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 4 | 0 | 0 | 4 |
Disintegrin and metalloproteinase domain-containing protein 17 | 2 | 0 | 0 | 2 |
Inositol hexakisphosphate kinase 1 | 3 | 0 | 0 | 3 |
cytochrome P450 2C9, partial | 3 | 0 | 0 | 3 |
Tyrosine-protein phosphatase non-receptor type 1 | 0 | 2 | 0 | 2 |
Phosphoglycerate mutase 1 | 0 | 1 | 0 | 1 |
Tyrosine-protein phosphatase 1 | 0 | 1 | 0 | 1 |
Pyruvate kinase PKLR | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B10 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A9 | 0 | 1 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 1 | 2 | 3 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Cytochrome c oxidase subunit 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
Albumin | 0 | 1 | 1 | 2 |
Prostaglandin G/H synthase 1 | 0 | 2 | 1 | 3 |
Cytochrome P450 3A4 | 0 | 4 | 0 | 4 |
Interleukin-8 | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha | 0 | 1 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 2 | 0 | 3 |
Fatty acid-binding protein, intestinal | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 2 |
UDP-glucuronosyltransferase 1-6 | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A1 | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
C-X-C chemokine receptor type 1 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 1 |
UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A7 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A10 | 0 | 1 | 0 | 1 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 3 | 0 | 0 | 3 |
hypoxia-inducible factor 1 alpha subunit | 2 | 0 | 0 | 2 |
RAR-related orphan receptor gamma | 4 | 0 | 0 | 4 |
AR protein | 4 | 0 | 0 | 4 |
nuclear receptor subfamily 1, group I, member 3 | 4 | 0 | 0 | 4 |
retinoic acid nuclear receptor alpha variant 1 | 4 | 0 | 0 | 4 |
estrogen-related nuclear receptor alpha | 4 | 0 | 0 | 4 |
estrogen nuclear receptor alpha | 4 | 0 | 0 | 4 |
euchromatic histone-lysine N-methyltransferase 2 | 3 | 0 | 0 | 3 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 3 | 0 | 0 | 3 |
Histone H2A.x | 3 | 0 | 0 | 3 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 4 | 0 | 0 | 4 |
Eyes absent homolog 2 | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 3 | 0 | 0 | 3 |
Voltage-dependent calcium channel gamma-2 subunit | 3 | 0 | 0 | 3 |
Cellular tumor antigen p53 | 4 | 0 | 0 | 4 |
Amyloid-beta precursor protein | 0 | 2 | 1 | 3 |
Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
Glutamate receptor 2 | 3 | 0 | 0 | 3 |
Metallo-beta-lactamase VIM-13 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase VIM-1 | 0 | 1 | 0 | 1 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 1 | 0 | 0 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 2 | 0 | 0 | 2 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
Chain A, Ferritin light chain | 1 | 0 | 0 | 1 |
Chain A, Cruzipain | 1 | 0 | 0 | 1 |
Luciferase | 2 | 0 | 0 | 2 |
acetylcholinesterase | 1 | 0 | 0 | 1 |
beta-amyloid peptide, A beta {N-terminal} [human, cerebrospinal fluid, conditioned medium of mixed-brain cell cultures, Peptide Partial, 33 aa] | 1 | 0 | 0 | 1 |
pregnane X receptor | 2 | 0 | 0 | 2 |
phosphopantetheinyl transferase | 1 | 0 | 0 | 1 |
SMAD family member 2 | 2 | 0 | 0 | 2 |
USP1 protein, partial | 1 | 0 | 0 | 1 |
SMAD family member 3 | 2 | 0 | 0 | 2 |
TDP1 protein | 3 | 0 | 0 | 3 |
Microtubule-associated protein tau | 2 | 0 | 0 | 3 |
caspase 7, apoptosis-related cysteine protease | 2 | 0 | 0 | 2 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 3 | 0 | 0 | 3 |
thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
alpha synuclein, partial | 1 | 0 | 0 | 1 |
hypothetical protein, conserved | 1 | 0 | 0 | 1 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 2 | 0 | 0 | 2 |
glucocorticoid receptor [Homo sapiens] | 3 | 0 | 0 | 3 |
farnesoid X nuclear receptor | 2 | 0 | 0 | 2 |
pregnane X nuclear receptor | 3 | 0 | 0 | 3 |
cytochrome P450 2D6 | 2 | 0 | 0 | 2 |
67.9K protein | 2 | 0 | 0 | 2 |
glucocerebrosidase | 1 | 0 | 0 | 1 |
luciferase | 1 | 0 | 0 | 1 |
peroxisome proliferator-activated receptor delta | 2 | 0 | 0 | 2 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 4 | 0 | 0 | 4 |
caspase-3 | 2 | 0 | 0 | 2 |
aryl hydrocarbon receptor | 2 | 0 | 0 | 2 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 3 | 0 | 0 | 3 |
thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
activating transcription factor 6 | 1 | 0 | 0 | 1 |
thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 1 | 0 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 2 | 1 | 0 | 0 | 1 |
Caspase-7 | 1 | 0 | 0 | 1 |
Bloom syndrome protein isoform 1 | 2 | 0 | 0 | 2 |
cellular tumor antigen p53 isoform a | 2 | 0 | 0 | 2 |
tumor necrosis factor | 1 | 0 | 0 | 1 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
vitamin D3 receptor isoform VDRA | 2 | 0 | 0 | 2 |
thyroid hormone receptor beta isoform a | 2 | 0 | 0 | 2 |
caspase-3 | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform 2 | 3 | 0 | 0 | 3 |
histone deacetylase 9 isoform 3 | 2 | 0 | 0 | 2 |
heat shock protein beta-1 | 1 | 0 | 0 | 1 |
huntingtin isoform 2 | 2 | 0 | 0 | 2 |
mitogen-activated protein kinase 1 | 1 | 0 | 0 | 1 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 1 | 2 |
nuclear receptor ROR-gamma isoform 1 | 3 | 0 | 0 | 3 |
DNA polymerase kappa isoform 1 | 2 | 0 | 0 | 2 |
peripheral myelin protein 22 | 1 | 0 | 0 | 1 |
survival motor neuron protein isoform d | 2 | 0 | 0 | 2 |
cytochrome P450 3A4 isoform 1 | 2 | 0 | 0 | 2 |
lethal factor (plasmid) | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 2 | 0 | 0 | 2 |
Solute carrier family 22 member 1 | 0 | 0 | 0 | 1 |
Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
Integrin beta-3 | 2 | 0 | 0 | 2 |
Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
Integrin alpha-IIb | 2 | 0 | 0 | 2 |
Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
Adenosine receptor A3 | 0 | 2 | 0 | 2 |
Cytochrome P450 2D6 | 0 | 1 | 0 | 1 |
60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 2 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
Androgen receptor | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | 2 | 0 | 0 | 2 |
Alpha-1B adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit delta | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 2 | 0 | 0 | 2 |
Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 2 | 0 | 0 | 2 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
Substance-K receptor | 0 | 2 | 0 | 2 |
D(1A) dopamine receptor | 0 | 2 | 0 | 2 |
Acetylcholinesterase | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, kainate 1 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 2 | 0 | 0 | 2 |
Histamine H2 receptor | 0 | 2 | 0 | 2 |
Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 2 | 0 | 0 | 2 |
Adenosine receptor A2a | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 2 | 0 | 0 | 2 |
Mu-type opioid receptor | 0 | 2 | 0 | 2 |
D(3) dopamine receptor | 0 | 2 | 0 | 2 |
Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, kainate 2 | 1 | 0 | 0 | 1 |
Glutamate receptor ionotropic, kainate 3 | 1 | 0 | 0 | 1 |
Alpha-1A adrenergic receptor | 0 | 2 | 0 | 2 |
Nuclear receptor ROR-gamma | 3 | 0 | 0 | 3 |
Spike glycoprotein | 1 | 0 | 0 | 1 |
10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-3 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-2 | 2 | 0 | 0 | 2 |
Fatty-acid amide hydrolase 1 | 1 | 0 | 0 | 1 |
Inositol monophosphatase 1 | 2 | 0 | 0 | 2 |
Glutamate receptor ionotropic, kainate 4 | 1 | 0 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
Leukotriene B4 receptor 1 | 1 | 0 | 0 | 1 |
Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, kainate 5 | 1 | 0 | 0 | 1 |
10 kDa chaperonin | 0 | 1 | 0 | 1 |
GABA theta subunit | 2 | 0 | 0 | 2 |
ATPase family AAA domain-containing protein 5 | 2 | 0 | 0 | 2 |
Ataxin-2 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit epsilon | 2 | 0 | 0 | 2 |
Leukotriene B4 receptor 2 | 1 | 0 | 0 | 1 |
ATP-dependent phosphofructokinase | 2 | 0 | 0 | 2 |
Chain A, HADH2 protein | 2 | 0 | 0 | 2 |
Chain B, HADH2 protein | 2 | 0 | 0 | 2 |
thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
aldehyde dehydrogenase 1 family, member A1 | 2 | 0 | 0 | 2 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 1 | 0 | 0 | 1 |
Glucocorticoid receptor | 0 | 2 | 1 | 3 |
Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
Chain A, Troponin C, slow skeletal and cardiac muscles | 0 | 0 | 1 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
glp-1 receptor, partial | 1 | 0 | 0 | 1 |
thioredoxin reductase | 1 | 0 | 0 | 1 |
BRCA1 | 1 | 0 | 0 | 1 |
ClpP | 1 | 0 | 0 | 1 |
ATAD5 protein, partial | 1 | 0 | 0 | 1 |
regulator of G-protein signaling 4 | 1 | 0 | 0 | 1 |
Parkin | 1 | 0 | 0 | 1 |
P53 | 1 | 0 | 0 | 1 |
arylsulfatase A | 1 | 0 | 0 | 1 |
pyruvate kinase | 1 | 0 | 0 | 1 |
M18 aspartyl aminopeptidase | 0 | 1 | 0 | 1 |
IDH1 | 1 | 0 | 0 | 1 |
cathepsin L1 | 0 | 1 | 0 | 1 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 1 | 0 | 0 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
glucokinase regulatory protein | 1 | 0 | 0 | 1 |
DNA polymerase beta | 1 | 0 | 0 | 1 |
atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
ras-related protein Rab-9A | 1 | 0 | 0 | 1 |
serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
FAD-linked sulfhydryl oxidase ALR | 0 | 0 | 0 | 1 |
DNA polymerase iota isoform a (long) | 1 | 0 | 0 | 1 |
urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
plasminogen precursor | 1 | 0 | 0 | 1 |
urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
Vif | 0 | 1 | 0 | 1 |
M-phase phosphoprotein 8 | 1 | 0 | 0 | 1 |
muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 0 | 1 | 0 | 1 |
transcription factor p65 isoform 1 | 0 | 0 | 1 | 1 |
serine/threonine-protein kinase 33 isoform a | 0 | 0 | 1 | 1 |
POsterior Segregation | 0 | 0 | 1 | 1 |
Aryl hydrocarbon receptor | 0 | 1 | 0 | 1 |
Estrogen receptor beta | 0 | 0 | 1 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Polyphenol oxidase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 12 | 0 | 1 | 0 | 1 |
Lysine-specific histone demethylase 1A | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase ABL1 | 0 | 1 | 0 | 2 |
Myc proto-oncogene protein | 0 | 1 | 0 | 2 |
Estrogen receptor | 0 | 1 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 1 | 0 | 1 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 1 | 0 | 1 |
Cathepsin D | 0 | 1 | 0 | 1 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 2 |
Luciferin 4-monooxygenase | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
DNA polymerase alpha catalytic subunit | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Breakpoint cluster region protein | 0 | 1 | 0 | 2 |
Tyrosinase | 0 | 2 | 0 | 2 |
Aromatase | 0 | 2 | 0 | 2 |
Ornithine decarboxylase | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 1 | 0 | 1 |
Tyrosinase | 0 | 1 | 0 | 1 |
Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 2 | 1 | 3 |
Protein kinase C alpha type | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 0 | 0 | 1 |
Estrogen receptor | 0 | 0 | 1 | 1 |
Nuclear factor NF-kappa-B p105 subunit | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
Endothelin receptor type B | 1 | 0 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 6 | 0 | 1 | 0 | 1 |
Sucrase-isomaltase, intestinal | 0 | 1 | 0 | 1 |
Sodium-dependent noradrenaline transporter | 0 | 2 | 1 | 3 |
Endothelin-1 receptor | 1 | 0 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 | 0 | 1 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 1 | 0 | 1 |
Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
Alpha-glucosidase MAL12 | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 1 | 0 | 1 |
Nuclear factor NF-kappa-B p100 subunit | 0 | 1 | 0 | 1 |
Squalene synthase | 0 | 1 | 0 | 1 |
Transcription factor p65 | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 0 | 0 | 1 |
Bcl-2-like protein 1 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase PAK 1 | 0 | 1 | 0 | 1 |
Nuclear factor erythroid 2-related factor 2 | 0 | 0 | 1 | 2 |
Cytochrome P450 1B1 | 0 | 2 | 0 | 2 |
N1L | 0 | 1 | 0 | 1 |
NAD(P)H dehydrogenase [quinone] 1 | 0 | 0 | 0 | 2 |
Tubulin beta-2B chain | 0 | 1 | 0 | 1 |
Lysosomal alpha-glucosidase | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 1 | 0 | 1 |
Similar to alpha-tubulin isoform 1 | 0 | 1 | 0 | 1 |
Similar to alpha-tubulin isoform 1 | 0 | 1 | 0 | 1 |
NAD-dependent protein deacetylase sirtuin-2 | 0 | 0 | 1 | 1 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
NAD-dependent protein deacetylase sirtuin-1 | 0 | 0 | 1 | 3 |
Carbonic anhydrase 15 | 0 | 1 | 0 | 1 |
Prenyltransferase homolog | 0 | 0 | 0 | 1 |
NAD-dependent protein deacetylase sirtuin-3, mitochondrial | 0 | 0 | 1 | 1 |
Carbonic anhydrase 14 | 0 | 1 | 0 | 1 |
Zinc finger protein mex-5 | 0 | 0 | 1 | 1 |
Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 1 |
large T antigen | 0 | 1 | 0 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 1 |
Solute carrier family 2, facilitated glucose transporter member 9 | 0 | 1 | 1 | 2 |
Guanine deaminase | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |